PubRank

Tawee Tanvetyanon

Author PubWeight™ 33.74‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Phase II efficacy and pharmacogenomic study of Selumetinib (AZD6244; ARRY-142886) in iodine-131 refractory papillary thyroid carcinoma with or without follicular elements. Clin Cancer Res 2012 2.02
2 Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer. J Clin Oncol 2007 1.91
3 Phase I/II study of the Src inhibitor dasatinib in combination with erlotinib in advanced non-small-cell lung cancer. J Clin Oncol 2010 1.88
4 Randomized international phase III trial of ERCC1 and RRM1 expression-based chemotherapy versus gemcitabine/carboplatin in advanced non-small-cell lung cancer. J Clin Oncol 2013 1.55
5 Which patient with a do-not-intubate order is a candidate for noninvasive ventilation? Crit Care Med 2004 1.39
6 Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer. J Thorac Oncol 2008 1.26
7 Variance of SUVs for FDG-PET/CT is greater in clinical practice than under ideal study settings. Clin Nucl Med 2013 1.19
8 Metastatectomy for extra-cranial extra-adrenal non-small cell lung cancer solitary metastases: systematic review and analysis of reported cases. Lung Cancer 2011 0.94
9 Intensity-modulated radiation therapy as primary treatment for oropharyngeal squamous cell carcinoma. Head Neck 2013 0.88
10 Phase II trial of a GM-CSF-producing and CD40L-expressing bystander cell line combined with an allogeneic tumor cell-based vaccine for refractory lung adenocarcinoma. J Immunother 2013 0.87
11 A phase I, pharmacokinetic, and pharmacodynamic study of panobinostat, an HDAC inhibitor, combined with erlotinib in patients with advanced aerodigestive tract tumors. Clin Cancer Res 2014 0.86
12 A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer. J Natl Compr Canc Netw 2012 0.85
13 Severe anemia and marrow plasmacytosis as presentation of Sjögren's syndrome. Am J Hematol 2002 0.84
14 Rupture of a cerebral arteriovenous malformation in a patient treated with bevacizumab. J Thorac Oncol 2009 0.80
15 Effects of self-directed stress management training and home-based exercise on stress management skills in cancer patients receiving chemotherapy. Stress Health 2012 0.80
16 Repeat cytoreductive surgery and heated intraperitoneal chemotherapy may offer survival benefit for intraperitoneal mesothelioma: a single institution experience. Ann Surg Oncol 2013 0.79
17 Relationship of exercise to quality of life in cancer patients beginning chemotherapy. J Pain Symptom Manage 2011 0.79
18 Inaccurate glucose determination by fingerstick in a patient with peripheral arterial disease. Ann Intern Med 2002 0.78
19 Phase II trial of induction gemcitabine and carboplatin followed by conformal thoracic radiation to 74 Gy with weekly paclitaxel and carboplatin in unresectable stage III non-small cell lung cancer. J Thorac Oncol 2011 0.77
20 Proton pump inhibitors and iron deficiency: is the connection real? South Med J 2004 0.76
21 Smoking Cessation, Version 1.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2016 0.76
22 Consideration before administering cytotoxic chemotherapy to the critically ill. Crit Care Med 2005 0.75
23 Re: Cost-effectiveness of zoledronic acid for the prevention of skeletal complications in patients with prostate cancer. J Urol 2004 0.75
24 Treatment of localized lymphoma. N Engl J Med 2005 0.75
25 Screening for primary human immunodeficiency virus infection. Arch Intern Med 2004 0.75
26 Cetuximab in head and neck cancer. N Engl J Med 2008 0.75
27 Is hypocalcemia during therapy with zoledronic acid or other bisphosphonates beneficial to cancer patients? Med Hypotheses 2004 0.75
28 Treatment of von Willebrand's Disease. N Engl J Med 2004 0.75
29 Long-term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors. Cancer 2005 0.75
30 Re: Long-term efficacy of zoledronic acid for the prevention of skeletal complications in patients with metastatic hormone-refractory prostate cancer. J Natl Cancer Inst 2005 0.75
31 HER-2 and fluorescent in situ hybridization to evaluate breast cancer. JAMA 2004 0.75
32 Arterial thrombosis in systemic lupus erythematosus. N Engl J Med 2004 0.75
33 Telephone psychotherapy and care management for depression. JAMA 2004 0.75
34 Medical costs associated with chiropractic care. Arch Intern Med 2005 0.75
35 Adjuvant treatment of breast cancer with exemestane. N Engl J Med 2004 0.75
36 Molecular prediction of recurrence of breast cancer. N Engl J Med 2005 0.75
37 Talking about death with dying children. N Engl J Med 2005 0.75
38 Octreotide for bleeding as a result of hepatocellular carcinoma invasion of the gastrointestinal tract. J Gastroenterol Hepatol 2003 0.75
39 Understanding the uncommon thoracic tumors. Cancer Control 2006 0.75
40 Second allogeneic transplantation using a reduced-intensity preparative regimen for relapsed myelofibrosis. Am J Hematol 2004 0.75
41 The European Organization for Research and Treatment of Cancer quality of life questionnaire: translation and reliability study of the Thai version. J Med Assoc Thai 2002 0.75